Emcure Pharmaceuticals Statistics

Total Valuation

Emcure Pharmaceuticals has a market cap or net worth of INR 260.07 billion. The enterprise value is 271.48 billion.

Market Cap	260.07B
Enterprise Value	271.48B

Important Dates

The next estimated earnings date is Thursday, February 6, 2025.

Earnings Date	Feb 6, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+1.11%
Shares Change (QoQ)	+3.93%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	6.10M

Valuation Ratios

The trailing PE ratio is 45.85.

PE Ratio	45.85
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	8.35
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 20.68, with an EV/FCF ratio of 41.24.

EV / Earnings	47.86
EV / Sales	3.74
EV / EBITDA	20.68
EV / EBIT	28.37
EV / FCF	41.24

Financial Position

The company has a current ratio of 1.57, with a Debt / Equity ratio of 0.28.

Current Ratio	1.57
Quick Ratio	0.83
Debt / Equity	0.28
Debt / EBITDA	0.91
Debt / FCF	1.81
Interest Coverage	5.07

Financial Efficiency

Return on equity (ROE) is 16.49% and return on invested capital (ROIC) is 11.32%.

Return on Equity (ROE)	16.49%
Return on Assets (ROA)	8.06%
Return on Capital (ROIC)	11.32%
Revenue Per Employee	6.69M
Profits Per Employee	522,737
Employee Count	10,852
Asset Turnover	0.98
Inventory Turnover	1.78

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	1,396.72
200-Day Moving Average	n/a
Relative Strength Index (RSI)	48.01
Average Volume (20 Days)	5,953

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Emcure Pharmaceuticals had revenue of INR 72.56 billion and earned 5.67 billion in profits. Earnings per share was 31.02.

Revenue	72.56B
Gross Profit	44.31B
Operating Income	9.57B
Pretax Income	8.19B
Net Income	5.67B
EBITDA	12.73B
EBIT	9.57B
Earnings Per Share (EPS)	31.02

Full Income Statement

Balance Sheet

The company has 2.32 billion in cash and 11.89 billion in debt, giving a net cash position of -9.56 billion.

Cash & Cash Equivalents	2.32B
Total Debt	11.89B
Net Cash	-9.56B
Net Cash Per Share	n/a
Equity (Book Value)	43.03B
Book Value Per Share	218.65
Working Capital	16.24B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 9.03 billion and capital expenditures -2.45 billion, giving a free cash flow of 6.58 billion.

Operating Cash Flow	9.03B
Capital Expenditures	-2.45B
Free Cash Flow	6.58B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 61.07%, with operating and profit margins of 13.19% and 7.82%.

Gross Margin	61.07%
Operating Margin	13.19%
Pretax Margin	11.28%
Profit Margin	7.82%
EBITDA Margin	17.54%
EBIT Margin	13.19%
FCF Margin	9.07%

Dividends & Yields

Emcure Pharmaceuticals does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	6.38%
Buyback Yield	-1.11%
Shareholder Yield	-1.11%
Earnings Yield	2.27%
FCF Yield	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	n/a